David A. Siegel Edgewise Therapeutics, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 92,400 shares of EWTX stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
92,400
Previous 40,900
125.92%
Holding current value
$1.66 Million
Previous $447,000
276.96%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding EWTX
# of Institutions
129Shares Held
76.3MCall Options Held
14.7KPut Options Held
14.8K-
Orbimed Advisors LLC San Diego, CA15MShares$271 Million6.17% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$105 Million1.35% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$93.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$72.4 Million0.0% of portfolio
-
Viking Global Investors LP3.34MShares$60.1 Million0.23% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.14B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...